JPMorgan Chase & Co. Issues Positive Forecast for CVS Health (NYSE:CVS) Stock Price

CVS Health (NYSE:CVS) had its target price lifted by stock analysts at JPMorgan Chase & Co. from $93.00 to $101.00 in a report issued on Wednesday,MarketScreener reports. The brokerage presently has an “overweight” rating on the pharmacy operator’s stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 29.77% from the stock’s current price.

Several other equities analysts have also recently commented on the stock. Wolfe Research upped their target price on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, December 8th. Barclays increased their price objective on shares of CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. The Goldman Sachs Group increased their price target on shares of CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Morgan Stanley raised their price target on shares of CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Finally, UBS Group reissued an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.67.

CVS Health Price Performance

Shares of CVS Health stock opened at $77.83 on Wednesday. CVS Health has a 1-year low of $43.56 and a 1-year high of $85.15. The firm has a fifty day simple moving average of $79.05 and a 200-day simple moving average of $72.20. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $98.80 billion, a price-to-earnings ratio of 206.18, a PEG ratio of 0.79 and a beta of 0.48.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the previous year, the business earned $1.09 EPS. The business’s revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, sell-side analysts expect that CVS Health will post 5.89 earnings per share for the current year.

Institutional Investors Weigh In On CVS Health

Large investors have recently bought and sold shares of the business. SOA Wealth Advisors LLC. lifted its holdings in CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after buying an additional 131 shares during the period. Alteri Wealth LLC lifted its stake in shares of CVS Health by 3.2% in the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after purchasing an additional 131 shares during the period. Holistic Financial Partners boosted its position in shares of CVS Health by 4.1% during the third quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock valued at $256,000 after purchasing an additional 133 shares in the last quarter. CYBER HORNET ETFs LLC grew its stake in CVS Health by 4.1% in the third quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after purchasing an additional 134 shares during the period. Finally, Fayez Sarofim & Co raised its holdings in CVS Health by 2.1% in the third quarter. Fayez Sarofim & Co now owns 6,913 shares of the pharmacy operator’s stock worth $521,000 after purchasing an additional 140 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.